Antibody-dependent enhancement and COVID-19: Moving toward acquittal

• Immunoglobulins represent an effective therapeutic option for the treatment of COVID-19. • Experimental findings of ADE with related coronaviruses provoked theoretical concerns of enhancing antibodies with COVID-19. • Emerging experimental and clinical data alleviate concerns and indorse the safet...

Descripción completa

Detalles Bibliográficos
Autor principal: Yager, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832065/
https://www.ncbi.nlm.nih.gov/pubmed/32526272
http://dx.doi.org/10.1016/j.clim.2020.108496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832065/
https://www.ncbi.nlm.nih.gov/pubmed/32526272
http://dx.doi.org/10.1016/j.clim.2020.108496

Ejemplares similares